We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+6.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.91%
AUM
$49.2B
AUM Growth
+$3.24B
(+7.1%)
Cap. Flow
+$512M
Cap. Flow
% of AUM
1.04%
Top 10 Holdings %
Top 10 Hldgs %
15.87%
Holding
2,920
New
16
Increased
1,206
Reduced
1,586
Closed
85
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$23.3M |
| 2 |
Becton Dickinson
BDX
|
+$18.4M |
| 3 |
Amazon
AMZN
|
+$16.1M |
| 4 |
Berkshire Hathaway Class B
BRK.B
|
+$15.4M |
| 5 |
Johnson & Johnson
JNJ
|
+$14.6M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
BCR
CR Bard Inc.
BCR
|
+$48.1M |
| 2 |
LVLT
Level 3 Communications Inc
LVLT
|
+$27.7M |
| 3 |
KITE
Kite Pharma, Inc.
KITE
|
+$10.7M |
| 4 |
PRXL
Parexel International Corp
PRXL
|
+$10.3M |
| 5 |
CELG
Celgene Corp
CELG
|
+$10.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.9% |
| 2 | Technology | 16.24% |
| 3 | Healthcare | 13.01% |
| 4 | Industrials | 10.83% |
| 5 | Consumer Discretionary | 9.6% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
AFSI
1826
DELISTED
AmTrust Financial Services, Inc.
AFSI
| $1.31M | ﹤0.01% |
130,443
-23,467
| -15% | -$266K |
|
|
IVC
1827
DELISTED
Invacare Corporation
IVC
| $1.31M | ﹤0.01% |
77,930
+10,666
| +16% | +$174K |
|
|
HEES
1828
DELISTED
H&E Equipment Services
HEES
| $1.31M | ﹤0.01% |
32,238
-5,860
| -15% | -$201K |
|
1829
Extreme Networks
EXTR
$3.94B
| $1.31M | ﹤0.01% |
104,438
-19,202
| -16% | -$237K |
|
1830
OneMain Financial
OMF
$7.2B
| $1.31M | ﹤0.01% |
50,293
+2,132
| +4% | +$58.9K |
|
1831
Chesapeake Utilities
CPK
$3.19B
| $1.3M | ﹤0.01% |
16,608
-2,672
| -14% | -$216K |
|
|
HTO
1832
H2O America
HTO
$2.57B
| $1.3M | ﹤0.01% |
20,434
-2,642
| -11% | -$167K |
|
|
ZGNX
1833
DELISTED
Zogenix, Inc.
ZGNX
| $1.3M | ﹤0.01% |
32,438
+2,264
| +8% | +$87K |
|
|
IMPV
1834
DELISTED
Imperva, Inc.
IMPV
| $1.3M | ﹤0.01% |
32,688
-5,983
| -15% | -$249K |
|
1835
Moelis & Co
MC
$4.97B
| $1.3M | ﹤0.01% |
26,723
-3,109
| -10% | -$140K |
|
|
SGMO
1836
DELISTED
SANGAMO THERAPEUTICS INC
SGMO
| $1.3M | ﹤0.01% |
79,032
-9,784
| -11% | -$146K |
|
|
HSNI
1837
DELISTED
HSN, Inc.
HSNI
| $1.29M | ﹤0.01% |
32,072
-32,576
| -50% | -$1.29M |
|
1838
MarineMax
HZO
$759M
| $1.29M | ﹤0.01% |
68,215
+7,547
| +12% | +$145K |
|
1839
TriMas Corp
TRS
$1.43B
| $1.28M | ﹤0.01% |
48,001
-8,136
| -14% | -$217K |
|
|
ALX
1840
Alexander's
ALX
$1.3B
| $1.28M | ﹤0.01% |
3,241
-652
| -17% | -$269K |
|
|
AIMT
1841
DELISTED
Aimmune Therapeutics
AIMT
| $1.28M | ﹤0.01% |
33,863
-6,287
| -16% | -$203K |
|
|
FTR
1842
DELISTED
Frontier Communications Corp.
FTR
| $1.28M | ﹤0.01% |
189,450
+26,967
| +17% | +$252K |
|
1843
ANI Pharmaceuticals
ANIP
$1.8B
| $1.27M | ﹤0.01% |
19,789
+2,807
| +17% | +$175K |
|
1844
Camping World
CWH
$639M
| $1.27M | ﹤0.01% |
28,461
+3,135
| +12% | +$136K |
|
|
CYS
1845
DELISTED
CYS Investments Inc.
CYS
| $1.27M | ﹤0.01% |
158,579
-26,660
| -14% | -$221K |
|
1846
MACOM Technology Solutions
MTSI
$19.2B
| $1.27M | ﹤0.01% |
39,075
-7,147
| -15% | -$258K |
|
1847
Comtech Telecommunications
CMTL
$50.3M
| $1.26M | ﹤0.01% |
57,159
+7,336
| +15% | +$156K |
|
1848
IMAX
IMAX
$2.62B
| $1.25M | ﹤0.01% |
53,783
-10,470
| -16% | -$247K |
|
1849
Clearway Energy Class C
CWEN
$4.94B
| $1.23M | ﹤0.01% |
65,316
-11,082
| -15% | -$210K |
|
1850
QuidelOrtho
QDEL
$1.14B
| $1.23M | ﹤0.01% |
28,471
-5,040
| -15% | -$206K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2017 Portfolio in Review
As of Q4 2017, RhumbLine Advisers held 2,920 positions worth $49.2B, up 7.1% from $46B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Trading was light in Q4 2017: portfolio turnover was 3.5%. RhumbLine Advisers opened 16 new positions and exited 85, leaving the 2,920-position portfolio largely intact.
By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 17% a quarter earlier, followed by Technology and Healthcare.
- RhumbLine Advisers's largest Q4 2017 buy was Delphi Technologies PLC Ordinary Shares: 187,382 shares worth $9.83M.
- RhumbLine Advisers added most to Microsoft in Q4 2017, an estimated $23.3M increase.
- RhumbLine Advisers's biggest Q4 2017 reduction was Celgene Corp, cutting an estimated $10.2M.
- RhumbLine Advisers fully exited CR Bard Inc. in Q4 2017, selling an estimated $48.1M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $49.2B portfolio in Q4 2017.
- RhumbLine Advisers opened 16 new positions and closed 85 in Q4 2017.
- RhumbLine Advisers's portfolio value rose 7.1% quarter-over-quarter to $49.2B.
Based on RhumbLine Advisers's 13F filing for Q4 2017, filed 9 Feb 2018.